• 1至5月我区为企业和社会减负4200余万元 2019-11-14
  • 与美玩太极比较合适。美力大,俺可借力也可卸力!瞅准了,来个四两拨千斤吧。 2019-11-14
  • 一季度全国网民留言办理热度出炉 安徽积极回复排名第三 2019-10-02
  • 智能音箱靠平台补贴“砍”到百元以下 2019-10-02
  • 昨天中国元首才接见了美国国务卿,说中美合作将造福于两国人民和世界人民。风雨同舟,靠不住啊。 2019-08-27
  • 【省水保院】召开党风廉政建设领导小组会议 2019-08-18
  • 新鲜出炉 三款高颜值个性SUV你准备好了么? 2019-08-18
  • 北京天安门广场更换花卉 2019-08-01
  • 叙利亚礼俗(礼仪漫谈) 2019-08-01
  • 云南富源:开展专业心理辅导 确保部队安全稳定 2019-06-20
  • 家里面积小 谁还犯傻买餐桌呀?现在潮流这种设计 ——凤凰网房产 2019-06-08
  • 别让“屈原留下三天端午假”的段子再流传 2019-05-27
  • 带动乡亲干 各自有实招——三位农村社区党组织书记的故事 2019-05-27
  • New method developed to target cause of Parkinson's
    New method developed to target cause of Parkinson's

    Image credit: Shutterstock

    彩霸王一波中特:New method developed to target cause of Parkinson's

    王中王中特网一波中特网 www.zqcitp.shop The discovery of a new way to target and treat the leading genetic contributor to Parkinson's may open the way for a potential new clinical treatment.

    Researchers from Oxford’s Department of Physiology, Anatomy and Genetics (DPAG) have identified how the dysfunction of a key protein, LRRK2, causes the neurons affected in Parkinson's to lose their ability to effectively clear out cell components that have been damaged. This discovery has enabled the team to find a new way to target and correct this issue, paving the way for a potential new clinical treatment.

    Parkinson’s is a motor disorder caused by the loss of a specific sub-set of neurons located in the midbrain. Although the underlying mechanisms leading to the death of these neurons is still not well understood, one of the leading theories is that they die as they accumulate protein aggregates.

    Evidence from recent years points to lysosomes, the cellular organelle in neurons responsible for clearing out waste, as a leading culprit for the progression of Parkinson's. The lysosomes do not work well enough in those with the condition, which causes damaged cell components to build up and clump together.

    About 10% of Parkinson’s is genetic, and lysosomes are implicated in the progression of both the inherited condition and in those with no family history of disease. Mutations in the gene LRRK2 are the most common genetic cause of Parkinson's, and these mutations have been heavily implicated in causing the lysosomes to stop working properly. However, researchers have been trying to ascertain exactly what LRRK2 does for some time and the mechanism by which LRRK2 regulates lysosomal function is still not clear.

    In a new study, the Wade-Martins Group has identified for the first time both an important role of LRRK2 and a new way to target its dysfunction therapeutically. Lysosomes need to be acidic to work properly and effectively degrade the waste proteins, and the team's research demonstrates that LRRK2 regulates the way that lysosomes are acidic. In Parkinson’s, the mutated LRRK2 is not able to perform this function, so lysosomes lose their acidity as a result of LRRK2 dysfunction.

    They also found that a drug called clioquinol, currently used as an anti-parasitic drug, overcomes the effect of the mutant LRRK2 and restores the acidity of the lysosome and clears out the protein aggregates. Consequently, the team was able to restore the ability of the lysosomes to "chew up this pathological protein burden" (Prof Wade-Martins) and clear out the protein aggregates that are killing the neurons.

    This data identifies a novel mechanism of LRRK2 mutations and ultimately demonstrates the importance of LRRK2 in lysosomal biology, as well as the critical role of the lysosome in Parkinson's.

    Professor Richard Wade-Martins of Oxford’s Department of Physiology, Anatomy and Genetics (DPAG), said: ‘As the population in the United Kingdom gets older, we're all ageing, the incidence of Parkinson's is going to increase. We urgently need a better understanding of what causes the disease and then apply that knowledge to develop new therapies, and that is what our work has done. Our work identifies for the first time the very important role of LRRK2 in regulating the acidity and the normal function of the protein recycling centre, the lysosome, and identifies a new way to target this therapeutically in Parkinson's.’

    The successful use of clioquinol to reverse the effects of this mutation highlights the potential of drugs targeting the lysosome in future therapeutics of not only Parkinson's, but also other neurodegenerative diseases where lysosome dysfunction has been implicated.

    The full paper, ‘LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function,’ can be read in Human Molecular Genetics.

    This research has been joint funded by Parkinson’s UK and a Pitt-Tuckers Fellowship.

  • 1至5月我区为企业和社会减负4200余万元 2019-11-14
  • 与美玩太极比较合适。美力大,俺可借力也可卸力!瞅准了,来个四两拨千斤吧。 2019-11-14
  • 一季度全国网民留言办理热度出炉 安徽积极回复排名第三 2019-10-02
  • 智能音箱靠平台补贴“砍”到百元以下 2019-10-02
  • 昨天中国元首才接见了美国国务卿,说中美合作将造福于两国人民和世界人民。风雨同舟,靠不住啊。 2019-08-27
  • 【省水保院】召开党风廉政建设领导小组会议 2019-08-18
  • 新鲜出炉 三款高颜值个性SUV你准备好了么? 2019-08-18
  • 北京天安门广场更换花卉 2019-08-01
  • 叙利亚礼俗(礼仪漫谈) 2019-08-01
  • 云南富源:开展专业心理辅导 确保部队安全稳定 2019-06-20
  • 家里面积小 谁还犯傻买餐桌呀?现在潮流这种设计 ——凤凰网房产 2019-06-08
  • 别让“屈原留下三天端午假”的段子再流传 2019-05-27
  • 带动乡亲干 各自有实招——三位农村社区党组织书记的故事 2019-05-27
  • 北京pk10走势图片 江苏快三怎么买 棋牌手游外挂是假的吗 关于高频彩 安徽福利彩票中心 北京pc蛋蛋预测99 排列三走势图2元网吧 真人游戏有哪些互动 银行贷款买房出租赚钱 新疆35选7的开奖号14 彩经网北京11选5 九心精准一尾中特平 新时时彩走势 北京快3开奖结果下载 幸运飞艇开奖号码 陕西11选5基本走势图表